“Identification of RUNX1 and IFNGR2 As Prognostic-Related Biomarkers Correlated With Immune Infiltration and Subtype Differentiation of Low-Grade Glioma”. 2023. Biomolecules and Biomedicine 23 (3): 405–425. https://doi.org/10.17305/bjbms.2022.8086.